Results 41 to 50 of about 5,249 (228)

Safety and efficacy of a feed additive consisting of Macleaya cordata (Willd.) R. Br. extract and leaves (Sangrovit® extra) for all poultry species (excluding laying and breeding birds) (Phytobiotics Futterzusatzstoffe GmbH)

open access: yesEFSA Journal, 2023
Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of Macleaya cordata (Willd.) R. Br.
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)   +23 more
doaj   +1 more source

Sanguinarine Protects Channel Catfish against Aeromonas hydrophila Infection by Inhibiting Aerolysin and Biofilm Formation

open access: yesPathogens, 2022
Aeromonas hydrophila is a pathogenic bacterium that can cause serious infections both in humans and aquatic animals. Antibiotics are the main approach for fighting against the pathogen.
Lushan Zhang   +5 more
doaj   +1 more source

Disruption of nucleocytoplasmic trafficking of cyclin D1 and topoisomerase II by sanguinarine

open access: yesBMC Cell Biology, 2006
Background The quaternary isoquinoline alkaloid sanguinarine is receiving increasing attention as a potential chemotherapeutic agent in the treatment of cancer.
Perkins Edward, Lamont Genelle, Holy Jon
doaj   +1 more source

Metabolism and Tissue Distribution of Chelerythrine and Effects of Macleaya Cordata Extracts on Liver NAD(P)H Quinone Oxidoreductase

open access: yesFrontiers in Veterinary Science, 2021
Background:Macleaya cordata (Willd.) (Papaveraceae) is listed as a feed additive in animal production by the European Food Authority.Methods: The metabolites of chelerythrine in rats were measured in vitro and in vivo by rapid and accurate high ...
Chong-Yin Huang   +8 more
doaj   +1 more source

Molecular Determinants of Sensitivity or Resistance of Cancer Cells Toward Sanguinarine

open access: yesFrontiers in Pharmacology, 2018
For decades, natural products represented a significant source of diverse and unique bioactive lead compounds in drug discovery field. In Clinical oncology, complete tumors remission is hampered by the development of drug-resistance.
Mohamed E. M. Saeed   +5 more
doaj   +1 more source

Alkaloid Biosynthesis in the Early Stages of the Germination of Argemone mexicana L. (Papaveraceae)

open access: yesPlants, 2021
The synthesis of the benzylisoquinoline alkaloids, sanguinarine and berberine, was monitored in Argemone mexicana L. (Papaveracea) throughout the early stages of its hypocotyl and seedling development.
Jorge Xool-Tamayo   +4 more
doaj   +1 more source

Come-back of phenanthridine and phenanthridinium derivatives in 21st century [PDF]

open access: yes, 2014
Phenanthridine derivatives are one of the most intensively studied families of biologically active compounds with efficient DNA binding ; attracting attention about time of DNA structure discovery (1960ies), early recognized as a symbol of DNA ...
Piantanida, Ivo   +2 more
core   +2 more sources

Assessing Performance and Safety of Feeding a Standardized Macleaya cordata Extract to Calves

open access: yesAnimals, 2022
This study examined the effects of Sangrovit®, a Macleaya cordata plant extract (MCE) preparation on feed intake, growth, blood chemistry, and tissue-residue levels of calves.
Ray A. Matulka   +4 more
doaj   +1 more source

Perbandingan Oral Care Menggunakan Povidone Iodine 1% Dengan Chlorhexidine 0.2% Terhadap Jumlah Bakteri Di Mulut Pada Pasien Penurunan Kesadaran [PDF]

open access: yes, 2015
The oral care of unconscious patients should not be ignored and requires oral antiseptics that have antibacterial properties. This research was a quasi-experimental design with control groups, using pre-post test design.
Nasution, Y. (Yusron)   +1 more
core   +1 more source

Hepatotoxicity induced by greater celandine (Chelidonium majus L.): a review of the literature [PDF]

open access: yes, 2017
The available literature assessing Chelidonium majus L. (CM) hepatotoxicity potential, and its risk to benefit assessment has been reviewed in this paper.
Busardò, F. P   +6 more
core  

Home - About - Disclaimer - Privacy